PW 2102
Latest Information Update: 25 Apr 2007
At a glance
- Originator Penwest Pharmaceuticals
- Class Antihypertensives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 25 Apr 2007 Discontinued - Preclinical for Hypertension in USA (unspecified route)
- 17 Oct 2003 Preclinical trials in Hypertension in USA (unspecified route)